Ocular Surgery News | The recent approval of pegcetacoplan for geographic atrophy, which may be followed shortly by avacincaptad pegol, is the first milestone answer to an unmet need, giving hope to patients who so far had no treatment options.It also paves the way for revolutionary changes in clinical practice, research, investment decisions and health care planning.